PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Restless legs syndrome, insomnia and brain chemistry: A tangled mystery solved?

2013-05-07
(Press-News.org) Johns Hopkins researchers believe they may have discovered an explanation for the sleepless nights associated with restless legs syndrome (RLS), a symptom that persists even when the disruptive, overwhelming nocturnal urge to move the legs is treated successfully with medication.

Neurologists have long believed RLS is related to a dysfunction in the way the brain uses the neurotransmitter dopamine, a chemical used by brain cells to communicate and produce smooth, purposeful muscle activity and movement. Disruption of these neurochemical signals, characteristic of Parkinson's disease, frequently results in involuntary movements. Drugs that increase dopamine levels are mainstay treatments for RLS, but studies have shown they don't significantly improve sleep. An estimated 5 percent of the U.S. population has RLS.

The small new study, headed by Richard P. Allen, Ph.D., an associate professor of neurology at the Johns Hopkins University School of Medicine, used MRI to image the brain and found glutamate — a neurotransmitter involved in arousal — in abnormally high levels in people with RLS. The more glutamate the researchers found in the brains of those with RLS, the worse their sleep.

The findings are published in the May issue of the journal Neurology. "We may have solved the mystery of why getting rid of patients' urge to move their legs doesn't improve their sleep," Allen says. "We may have been looking at the wrong thing all along, or we may find that both dopamine and glutamate pathways play a role in RLS."

For the study, Allen and his colleagues examined MRI images and recorded glutamate activity in the thalamus, the part of the brain involved with the regulation of consciousness, sleep and alertness. They looked at images of 28 people with RLS and 20 people without. The RLS patients included in the study had symptoms six to seven nights a week persisting for at least six months, with an average of 20 involuntary movements a night or more.

The researchers then conducted two-day sleep studies in the same individuals to measure how much rest each person was getting. In those with RLS, they found that the higher the glutamate level in the thalamus, the less sleep the subject got. They found no such association in the control group without RLS.

Previous studies have shown that even though RLS patients average less than 5.5 hours of sleep per night, they rarely report problems with excessive daytime sleepiness. Allen says the lack of daytime sleepiness is likely related to the role of glutamate, too much of which can put the brain in a state of hyperarousal — day or night.

If confirmed, the study's results may change the way RLS is treated, Allen says, potentially erasing the sleepless nights that are the worst side effect of the condition. Dopamine-related drugs currently used in RLS do work, but many patients eventually lose the drug benefit and require ever higher doses. When the doses get too high, the medication actually can make the symptoms much worse than before treatment. Scientists don't fully understand why drugs that increase the amount of dopamine in the brain would work to calm the uncontrollable leg movement of RLS.

Allen says there are already drugs on the market, such as the anticonvulsive gabapentin enacarbil, that can reduce glutamate levels in the brain, but they have not been given as a first-line treatment for RLS patients.

RLS wreaks havoc on sleep because lying down and trying to relax activates the symptoms. Most people with RLS have difficulty falling asleep and staying asleep. Only getting up and moving around typically relieves the discomfort. The sensations range in severity from uncomfortable to irritating to painful.

"It's exciting to see something totally new in the field — something that really makes sense for the biology of arousal and sleep," Allen says.

As more is understood about this neurobiology, the findings may not only apply to RLS, he says, but also to some forms of insomnia. ### The study was funded in part by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (R01 NS075184 and NS044862), the National Institute on Aging (P10-AG21190) and the National Center for Research Resources (M01RR02719).

Allen has received honoraria serving on advisory boards from impax, Pfizer and UCB and honoraria for scientific lectures, consultancy and research support from UCB, GSK, Pfizer and Pharmacosmos.

Other Johns Hopkins researchers involved in the study include Peter B. Barker, D.Phil.; Alena Horska, Ph.D.; and Christopher J. Earley, M.D., Ph.D.

For more information:

http://www.hopkinsmedicine.org/neurology_neurosurgery/specialty_areas/restless-legs-syndrome/

Media Contact: Stephanie Desmon
410-955-8665; sdesmon1@jhmi.edu Helen Jones; 410-502-9422; hjones49@jhmi.edu


ELSE PRESS RELEASES FROM THIS DATE:

Older adults' memory lapses linked to problems processing everyday events

2013-05-07
Some memory problems common to older adults may stem from an inability to segment daily life into discrete experiences, according to a new study published in Psychological Science, a journal of the Association for Psychological Science. The study suggests that problems processing everyday events may be the result of age-related atrophy to a part of the brain called the medial temporal lobe (MTL). "When you think back on what you did yesterday, you don't just press 'play' and watch a continuous stream of 24 hours," says psychological scientist Heather Bailey of Washington ...

When women sell themselves short on team projects

2013-05-07
May 7, 2013 - Working on a team is always a challenge, but a new study highlights a particular challenge to women: how much they credit themselves in a joint success. Women will devalue their contributions when working with men but not with other women, according to the new research. The study suggests yet another reason why women still tend to be under-represented at the highest echelons of many organizations. Michelle Haynes of the University of Massachusetts, Lowell, had examined how other people evaluate men and women working together. She decided to build on that ...

Nerve stimulation for severe depression changes brain function

2013-05-07
For nearly a decade, doctors have used an implanted electronic stimulator to treat severe depression in people who don't respond to standard antidepressant therapy. Now, preliminary brain scan studies conducted by researchers at Washington University School of Medicine in St. Louis are beginning to reveal the processes occurring in the brain during stimulation and may provide some clues about how the device improves depression. They found that vagus nerve stimulation brings about changes in brain metabolism weeks or even months before patients begin to feel better. The ...

Initiation of breast cancer treatment varies by race; patient-doctor communication is key

2013-05-07
WASHINGTON — Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days — a time delay associated with increased deaths from the disease, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center. But many women chose to forgo treatment altogether, and the study, published online in the May issue of Breast Cancer Research and Treatment, suggests that low satisfaction regarding communication between black women and their doctors is a significant reason ...

Decline in snow cover spells trouble for many plants, animals

2013-05-07
MADISON – For plants and animals forced to tough out harsh winter weather, the coverlet of snow that blankets the north country is a refuge, a stable beneath-the-snow habitat that gives essential respite from biting winds and subzero temperatures. But in a warming world, winter and spring snow cover in the Northern Hemisphere is in decline, putting at risk many plants and animals that depend on the space beneath the snow to survive the blustery chill of winter. In a report published May 2 in the journal Frontiers in Ecology and the Environment, a team of scientists ...

Study: MicroRNA cooperation mutes breast cancer oncogenes

2013-05-07
A University of Colorado Cancer Center study recently published in the journal Cell Death & Disease shows that turning up a few microRNAs a little may offer as much anti-breast-cancer activity as turning up one microRNA a lot – and without the unwanted side effects. It's a bit like the classic thought experiment known as the "tumor problem" formulated by Karl Dunker in 1945 and used frequently in the problem-solving literature: Imagine a person suffers from a malignant tumor in the center of her body. Radiation strong enough to kill the tumor kills any healthy tissue ...

ER visits for urinary tract infections add almost $4 billion a year in unnecessary costs

2013-05-07
SAN DIEGO – Giving patients better access to primary health care could save nearly $4 billion a year in unnecessary emergency room visits for a single common complaint – urinary tract infections – according to a study by the Vattikuti Urology Institute at Henry Ford Hospital in Detroit. The study set out to determine the economic burden of 10.8 million patients, with a primary diagnosis of urinary tract infection, who went to U.S. emergency rooms for treatment from the beginning of 2006 to the end of 2009. The findings will be presented May 6 at the annual meeting of ...

Annals of Internal Medicine tip sheet for May 7, 2013

2013-05-07
1. Ambrisentan Not Appropriate for Patients with Idiopathic Pulmonary Fibrosis Ambrisentan should not be used to treat patients for idiopathic pulmonary fibrosis (IPF). IPF is a fatal form of chronic, progressive lung disease characterized by irreversible scarring around both lungs. IPF causes about 5,000 deaths each year and currently there is no approved treatment. Researchers do not know what causes IPF, but a protein called endothelin-1 that causes the blood vessels to contract and induces lung scarring and proliferation has been associated with the disease. Researchers ...

MS may not be as rare as thought in African-Americans

2013-05-07
MINNEAPOLIS – Contrary to a widely accepted belief, African-Americans may have a higher rather than lower risk of developing multiple sclerosis (MS) than Caucasians, according to a new study in the May 7, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology. "Our population-based study is the first of its kind to look at this question. The belief (that African- Americans have a lower risk of developing MS) was based on evidence that was problematic," said study author Annette Langer-Gould, MD, with Kaiser Permanente Southern California ...

Helping kids with severe respiratory failure survive until lung transplantation

2013-05-07
Minneapolis, MN, May 6, 2013 – Adults with end-stage respiratory failure and pulmonary hypertension requiring ECMO (extracorporeal membrane oxygenation) have been "bridged" toward lung transplantation with novel lung assist devices such as the Novalung. This and related devices work based on pumpless application of oxygenators. A presentation by David M. Hoganson, MD, and colleagues from Washington University School of Medicine in St. Louis at the Congenital Heart Disease Session of the 93rd AATS Annual Meeting describes the first time application of this technology to ...

LAST 30 PRESS RELEASES:

Global prevalence of short-sightedness in children and teens set to top 740 million cases by 2050

Urgent rethink of bottled water’s huge and growing toll on human and planetary health

Women still missing out on treatment for their No 1 killer—cardiovascular disease

Palestinian education ‘under attack’, leaving a generation close to losing hope, study warns

Semaglutide improves outcomes for obese patients with common skin condition, new study shows

Could GLP1RA drugs lower high iron levels?

C-Path’s PKD outcomes consortium receives BAA Award for project to advance drug development tools for autosomal dominant tubulointerstitial kidney disease

New insights into hot carrier solar cells: Increasing generation and extraction

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

How emotion boosts memory for context

Specially designed video games may benefit mental health of children and teenagers

President Obama 2012 reelection linked to significantly better mental health in Black men — but only those with a college education

Finding the sweet spot: Machine learning reveals factors for successful crowdfunding

University of Houston unveils guideline to enhance treatment access for opioid use disorder in community pharmacies

Atmospheric methane increase during pandemic due primarily to wetland flooding

Violence, harassment from students is overwhelmingly ‘part of the job’ for Saskatchewan education sector workers

Thermal effects in spintronics systematically assessed for first time

Study shows rates of e-bike injuries rise fourfold and powered scooter injuries nearly double

Prediabetes during adolescence and young adulthood linked with likelihood of adverse pregnancy outcomes

Researchers discover new role of immune cells in eye health

Daniel R. Larson to receive 2025 Carolyn Cohen Innovation Award

James A. Glazier to receive 2025 Klaus Schulten and Zaida Luthey-Schulten Computational Biophysics Lecture Award

Better together: Gut microbiome communities’ resilience to drugs

More to munch on: The popcorn planet WASP-107b unveils new atmospheric details

Innovative electrolytes could transform steelmaking and beyond

Planting seeds for safer farming

Fruit-only diet improves bats’ immune response to viruses

Placebo pain relief and positive treatment expectations are not caused by dopamine

New guideline details how to manage CVD risk before, during & after noncardiac surgery

Silvia Cavagnero to receive 2025 Emily M. Gray Award

[Press-News.org] Restless legs syndrome, insomnia and brain chemistry: A tangled mystery solved?